U.S. markets closed
  • S&P Futures

    4,410.75
    -3.50 (-0.08%)
     
  • Dow Futures

    34,995.00
    -39.00 (-0.11%)
     
  • Nasdaq Futures

    15,111.25
    -6.50 (-0.04%)
     
  • Russell 2000 Futures

    2,208.50
    -4.90 (-0.22%)
     
  • Crude Oil

    72.00
    +0.09 (+0.13%)
     
  • Gold

    1,796.60
    -2.60 (-0.14%)
     
  • Silver

    25.17
    -0.15 (-0.60%)
     
  • EUR/USD

    1.1812
    +0.0004 (+0.04%)
     
  • 10-Yr Bond

    1.2760
    -0.0100 (-0.78%)
     
  • Vix

    17.58
    +0.38 (+2.21%)
     
  • GBP/USD

    1.3824
    -0.0000 (-0.00%)
     
  • USD/JPY

    110.2750
    -0.1000 (-0.09%)
     
  • BTC-USD

    37,287.70
    +1,531.28 (+4.28%)
     
  • CMC Crypto 200

    885.38
    -30.10 (-3.29%)
     
  • FTSE 100

    7,025.43
    -2.15 (-0.03%)
     
  • Nikkei 225

    27,970.10
    +136.81 (+0.49%)
     

Should Value Investors Choose Cigna Corporation (CI) Stock?

·6 min read

Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when compared to fair value?

One way to find these companies is by looking at several key metrics and financial ratios, many of which are crucial in the value stock selection process. Let’s Cigna Corporation CI stock into this equation and find out if it is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks:

PE Ratio

A key metric that value investors always look at is the Price to Earnings Ratio, or PE for short. This shows us how much investors are willing to pay for each dollar of earnings in a given stock, and is easily one of the most popular financial ratios in the world. The best use of the PE ratio is to compare the stock’s current PE ratio with: a) where this ratio has been in the past; b) how it compares to the average for the industry/sector; and c) how it compares to the market as a whole.

On this front, Cigna Corporation has a trailing twelve months PE ratio of 12.84, as you can see in the chart below:

Zacks Investment Research
Zacks Investment Research

Image Source: Zacks Investment Research

This level actually compares favorably with the market at large, as the PE for the S&P 500 stands at about 27.89. If we focus on the long-term PE trend Cigna Corporation’s current PE level puts it below its midpoint over the past five years. Moreover, the current level is fairly below the highs for this stock, suggesting it might be a good entry point.

Zacks Investment Research
Zacks Investment Research

Image Source: Zacks Investment Research

However, the stock’s PE also compares unfavorably with the Zacks Finance sector’s trailing twelve months PE ratio, which stands at 19.15. At the very least, this indicates that the stock is slightly undervalued right now, compared to its peers.

Zacks Investment Research
Zacks Investment Research

Image Source: Zacks Investment Research

We should also point out that Cigna Corporation has a forward PE ratio (price relative to this year’s earnings) of just 11.60, so it is fair to say that a slightly more value-oriented path may be ahead for Cigna Corporation’s stock in the near term too.

P/S Ratio

Another key metric to note is the Price/Sales ratio. This approach compares a given stock’s price to its total sales, where a lower reading is generally considered better. Some people like this metric more than other value-focused ones because it looks at sales, something that is far harder to manipulate with accounting tricks than earnings.

Right now, Cigna Corporation has a P/S ratio of about 0.51. This is lower than the S&P 500 average, which comes in at 5.22 right now. Also, as we can see in the chart below, this is somewhat below the highs for this stock in particular over the past few years.

Zacks Investment Research
Zacks Investment Research

Image Source: Zacks Investment Research

Broad Value Outlook

In aggregate, Cigna Corporation currently has a Value Score of A, putting it into the top 20% of all stocks we cover from this look. This makes Cigna Corporation a solid choice for value investors, and some of its other key metrics make this pretty clear too.

For example, the PEG ratio for Cigna Corporation comes in at 1.01, which is better than the industry average of 1.33. Clearly, CI is a solid choice on the value front from multiple angles.

What About the Stock Overall?

Though Cigna Corporation might be a good choice for value investors, there are plenty of other factors to consider before investing in this name. In particular, it is worth noting that the company has a Growth Score of C and Momentum Score of A. This gives Cigna Corporation a Zacks VGM score — or its overarching fundamental grade — of A. (You can read more about the Zacks Style Scores here >>)

Meanwhile, the company’s recent earnings estimates have been mixed, at the best. The current quarter estimate witnessed two upward revisions in the past sixty days compared to four downward revisions, while the current year estimate witnessed 10 upward revisions compared to no downward revision in the same time period.

This has had a noticeable impact on the consensus estimate, as the current quarter consensus estimate declined 0.8% in the past two months, whereas the current year estimate improved 0.7% in the past two months. You can see the consensus estimate trend and recent price action for the stock in the chart below:

Cigna Corporation Price and Consensus

Cigna Corporation Price and Consensus
Cigna Corporation Price and Consensus

Cigna Corporation price-consensus-chart | Cigna Corporation Quote

Owing to bearish estimate trends, the stock has a Zacks Rank #3 (Hold), which is why we are looking for in-line performance from the company in the near term.

Bottom Line

Cigna Corporation is an inspired choice for value investors, as it is hard to beat its incredible lineup of statistics on this front. However, with a Zacks Rank #3, it is hard to get too excited about this company overall. In fact, over the past two years, the sector has clearly underperformed the market at large, as you can see below:

Zacks Investment Research
Zacks Investment Research

Image Source: Zacks Investment Research

So, value investors might want to wait for estimates, analyst sentiment and broader factors to turn around in this name first, but once that happens, this stock could be a compelling pick.

Time to Invest in Legal Marijuana

If you’re looking for big gains, there couldn’t be a better time to get in on a young industry primed to skyrocket from $17.7 billion back in 2019 to an expected $73.6 billion by 2027.

After a clean sweep of 6 election referendums in 5 states, pot is now legal in 36 states plus D.C. Federal legalization is expected soon and that could be a still greater bonanza for investors. Even before the latest wave of legalization, Zacks Investment Research has recommended pot stocks that have shot up as high as +285.9%

You’re invited to check out Zacks’ Marijuana Moneymakers: An Investor’s Guide. It features a timely Watch List of pot stocks and ETFs with exceptional growth potential.

Today, Download Marijuana Moneymakers FREE >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Cigna Corporation (CI) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research